DrugSupplement
Andrographis paniculata extract clinical trials
Also written Andrographis Paniculata.
Keep track of what changes. Save the Andrographis paniculata extract studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2013 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 4
Hutchison Medipharma Limited (4) · Chinese University of Hong Kong (1) · Vedic Lifesciences Pvt. Ltd. (1) · Universitas Palangka Raya (1) · Mahidol University (1) · University of Malaya (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Andrographis paniculata extract is read from its arms, and is right about nine times in ten.
Testing it · 9
- Comparison of the Effectiveness of Sambiloto Herbs (Andrographis Paniculata) and Brisk Walking Exercise on Blood Pressure of Obese PatientsNot yet recruitingNot applicableUniversitas Palangka RayaNCT06520527Written as Andrographis paniculata
- The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal CancerCompletedPhase 3Chinese University of Hong KongNCT04196075Written as Andrographis Paniculata
- Andrographis Paniculata vs Boesenbergia Rotunda vs Control in Asymptomatic COVID-19Status unknownPhase 3Mahidol UniversityNCT05019326Written as Andrographis Paniculata
- Assessment of the Efficacy of Andrographis Paniculata in Subjects With Mild to Moderate OsteoarthritisCompletedNot applicableVedic Lifesciences Pvt. Ltd.NCT03262792Written as Andrographis Paniculata
- Phase II Study of HMPL-004 in Patients With Ulcerative ColitisCompletedPhase 2Hutchison Medipharma LimitedNCT00659802Written as HMPL-004 low dose
- HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative ColitisTerminatedPhase 3Hutchison Medipharma LimitedNCT01882764Written as HMPL-004
- Phase II Study of HMPL-004 in Subjects With Crohn's DiseaseCompletedPhase 2Hutchison Medipharma LimitedNCT00655733Written as HMPL-004
- A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative ColitisTerminatedPhase 3Hutchison Medipharma LimitedNCT01805791Written as HMPL-004 1800 mg/day
- Pharmacometabolomics of Andrographis Paniculata And Metformin In Healthy Volunteers Under Fasting ConditionStatus unknownPhase 1University of MalayaNCT04161404Written as Brand name: Andrographis paniculata (Shine Hempedu Bumi) 1000mg capsules
Codes
What other systems call Andrographis paniculata extract · ClinicalTrials.gg INT001532
- MeSH (NLM) C000713167Andrographis paniculata extractOne source NLM
- UNII (FDA) 0P49L952WZANDROGRAPHIS PANICULATA WHOLEConfirmed NLM, Wikidata
- RxNorm 1534766One source FDA
- Wikidata Q1551608Andrographis paniculataConfirmed NLM, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000713167 | Andrographis paniculata extract | One source NLM |
| UNII (FDA) | 0P49L952WZ | ANDROGRAPHIS PANICULATA WHOLE | Confirmed NLM, Wikidata |
| RxNorm | 1534766 | — | One source FDA |
| Wikidata | Q1551608 | Andrographis paniculata | Confirmed NLM, Wikidata |
Also registered as andrographis paniculata top (UNII I49U6EUL9X).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.